Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass

Anesthesiology

Volumn 89, Issue 1, 1998, Pages 93-104

  Hensel, Mario ^a   Volk, Thomas ^b   Döcke, Wolf D ^b   Kern, Florian ^b   Tschirna, Dirk ^b   Egerer, Karl ^b   Konertz, Wolfgang ^b   Kox, Wolfgang J ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b NONE

Author keywords

Cardiac surgery; Inflammation; Lung injury

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; LEUKOCYTE ELASTASE; NEOPTERIN; PROCALCITONIN; SELECTIN;

ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CYTOKINE RELEASE; DISEASE MARKER; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LUNG INJURY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SCORING SYSTEM;

AGED; BIOLOGICAL MARKERS; CALCITONIN; CORONARY ARTERY BYPASS; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROTEIN PRECURSORS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0031826811     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199807000-00016     Document Type: Article

References (35)

1. Butler J, Rocker GM, Westaby S: Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55:552-9
2. Verrier ED, Boyle EM: Endothelial cell injury in cardiovascular surgery. Ann Thorac Surg 1996; 62:915-22
3. Hall RI, Smith MS, Rocker G: The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 1997; 85:66-82
4. The ACCP/SCCM American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-74
5. Taylor KM: SIRS-The systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996; 61:1607-8
6. Cremer J, Martin M, Redl H, Bahrami S, Abraham C, Graeter T, Haverich A, Schlag G, Borst HG: Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996; 61:1714-20
7. Messent M, Sullivan K, Keogh BF, Morgan CJ, Evans TW: Adult respiratory distress syndrome following cardiopulmonary bypass: Incidence and prediction. Anaesthesia 1992; 47:267-8
8. Menasché P: The inflammatory response to cardiopulmonary bypass and its impact on postoperative myocardial function. Curr Opin Cardiol 1995; 10:597-604
9. Boldt J, Osmer C, Linke LC, Dapper F, Hempelmann G: Circulating adhesion molecules in pediatric cardiac surgery. Anesth Analg 1995; 81:1129-35
10. Goris RJ: Multiple organ failure: Whole body inflammation? Schweiz Med Wochenschr 1989; 119:347-53
11. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341:515-8
12. Murray JF, Matthay MA, Luce JM, Flick MR: An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138:720-3
13. Jolliet P, Thorens JB, Nicod L, Pichard C, Kyle U, Chevrolet JC: Relationship between pulmonary oxygen consumption, lung inflammation, and calculated venous admixture in patients with acute lung injury. Intensive Care Med 1996; 22:277-85
14. Hachenberg T, Tenling A, Rothen HU, Nyström SO, Tyden H, Hedenstierna G: Thoracic intravascular and extravascular fluid volumes in cardiac surgical patients. ANESTHESIOLOGY 1993; 79:976-84
15. Endo S, Inada K, Kasai T, Takakuwa T, Nakae H, Kikuchi M, Yamashita H, Yoshida M: Soluble CD 14 (sCD14) levels in patients with multiple organ failure (MOF). Res Commun Chem Pathol Pharmacol 1994; 84: 17-25
16. Berry CB, Butler PJ, Myles PS: Lung management during cardiopulmonary bypass: Is continuous positive airways pressure beneficial? Br J Anaesth 1993; 71:864-8
17. Friedman M, Sellke FW, Wang SY, Weintraub RM, Johnson RG: Parameters of pulmonary injury after total or partial cardiopulmonary bypass. Circulation 1994; 90:II-262-8
18. Utley JR: The history of the concept of inflammatory responses to cardiopulmonary bypass. Perfusion 1996; 11:190-5
19. Pennock J, Pierce W, Waldhausen J: The management of the lungs during cardiopulmonary bypass. Surg Gynecol Obstet 1977; 145:917-27
20. Sladen R, Jenkins L: Intermittent mandatory ventilation and controlled mechanical ventilation without positive end-expiratory pressure following cardiopulmonary bypass. Can Anaest Soc J 1978; 25:166-72
21. Asada S, Yamaguchi M: Fine structural change in the lung following cardiopulmonary bypass. Chest 1971; 59:478-83
22. Dreyer WJ, Michael LH, Millmann EE, Berens KL: Neutrophil activation and adhesion molecule expression in a canine model of open heart surgery with cardiopulmonary bypass. Cardiovasc Res 1995; 29:775-81
23. Galinanes M, Watson C, Trivedi U, Chambers DJ, Young CP, Venn GE: Differential patterns of neutrophil adhesion molecules during cardiopulmonary bypass in humans. Circulation 1996; 94:II-364-9
24. Sawa Y, Shimazaki Y, Kadoba K, Masai T, Fukuda H, Ohata T, Taniguchi K, Matsuda H: Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations. J Thorac Cardiovasc Surg 1996; 111:29-35
25. Smedly LA, Tonnesen MG, Sandhaus RA, Haslett C, Guthrie LA, Johnston RB, Henson PM, Worthen GS: Neutrophil-mediated injury to endothelial cells: Enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest 1986; 77:1233-43
26. Jochum M, Fritz H: Elastase and its inhibitors in intensive care medicine. Biomed Prog 1990; 3:55-9
27. Pilz G, Kaab S, Kreuzer E, Werdan K: Evaluation of definitions and parameters for sepsis assessment in patients after cardiac surgery. Infection 1994; 22:8-17
28. Wan S, Marchant A, DeSmet JM, Antoine M, Zhang H, Vachiery JL, Goldman M, Vincent JL, LeClerc JL: Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg 1996; 111:469-77
29. Butler J, Chong GL, Baigne RJ, Pillai R, Westaby S, Rocker GM: Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg 1992; 53:833-8
30. Aronen M, Leijala M, Meri S: Value of C-reactive protein in reflecting the magnitude of complement activation in children undergoing open heart surgery. Intensive Care Med 1990; 16:128-32
31. Nylen ES, Jeng J, Jordan MH, Snider RH, Thompson KA, Lewis MS, O'Neill WJ, Becker KL: Late pulmonary sequela following burns: Persistence of hyperprocalcitonemia using a-1-57 amino acid N-terminal flanking peptide assay. Resp Med 1995; 89:41-6
32. Smith MD, Suputtamongkol Y, Chaowagul W, Assicot M, Bohuon C, Petitjean S, White NJ: Elevated serum procalcitonin levels in patients with melioidosis. Clin Infect Dis 1995; 20:641-5
33. Nylén ES, Snider RH, Thompson KA, Rohatgi P, Becker KL: Pneumonitis-associated hyperprocalcitonemia. Am J Med Sci 1996; 312:12-8
34. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C: Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79:1605-8
35. Becker KL, Silva OL, Snider RH, Moore CF, Geelhoed GW, Nash D: The pathophysiology of pulmonary calcitonin. The endocrine lung in health and disease, Edited by KL Becker, AF Gazdar. Philadelphia, WB Saunders, 1984, pp 277-99